SCHEMBL23089656

SCHEMBL23089656

O=C(O)N1CCCC(O)(CN2CCOCC2)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
HSD17B10 Q99714 2/20 0.39
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
GLA P06280 1/20 0.37
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.35
MAP2K2 P36507 1/20 0.35
MAP2K1 Q02750 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
TACR2 P21452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23089269 0.83 POLB (0.39) POLBHSD17B10TSHRALOX15MEN1
SCHEMBL1935214 0.81 POLB (0.54) POLBHSD17B10TSHRALOX15GLA
SCHEMBL23090111 0.80 USP2 (0.51) POLBSMN1; SMN2HPGD
SCHEMBL9175762 0.79 POLB (0.35) POLBMEN1KMT2AALDH1A1MAP2K2
SCHEMBL23089494 0.78 PDCD1 (0.31)
SCHEMBL24859533 0.75 GAA (0.39) POLBHSD17B10TSHRALDH1A1SMN1; SMN2
SCHEMBL23109019 0.75 GAA (0.39) POLBHSD17B10TSHRALDH1A1SMN1; SMN2
SCHEMBL17693022 0.75 ALDH1A1 (0.44) POLBHSD17B10TSHRALOX15MEN1
SCHEMBL10514286 0.74 USP2 (0.36) TSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL23109025 0.73 LMNA (0.38) POLBTSHRALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028085-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists Nimbus Saturn, Inc. (US) 2021-06-08 US disclosed
US-11021481-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists Nimbus Saturn, Inc. (US) 2021-06-01 US disclosed
US-20210078996-A1 HPK1 ANTAGONISTS AND USES THEREOF CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) 2021-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028085-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists HIPK1, PDXK, IP6K1 POLB 3548/4885HSD17B10 1715/4885TSHR 4393/4885
US-20210078996-A1 HPK1 ANTAGONISTS AND USES THEREOF PDXK, HIPK1, PCK1 POLB 3344/4885HSD17B10 603/4885TSHR 4353/4885
US-11021481-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists HIPK1, PDXK, IP6K1 POLB 3548/4885HSD17B10 1715/4885TSHR 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.